Skip to main content

Table 5 Multivariate analyses of risk factors for OS and PFS

From: Role of the initial degree of anaemia and treatment model in the prognosis of gastric cancer patients treated by chemotherapy: a retrospective analysis

 

OS

PFS

p value

HR

95%CI

p value

HR

95%CI

HBini ≤ 80 g/L

0.001

1.879

1.301–2.767

0.016

1.516

1.082–2.126

metastatic sites ≥3

0.063

1.246

0.989–1.572

0.823

1.026

0.821–1.281

Liver metastases

0.029

1.234

1.022–1.490

0.057

1.188

0.885–1.420

Bone metastases

0.269

1.293

0.820–2.040

0.685

1.094

0.709–1.689

Chemotherapy included paclitaxel

0.036

1.225

1.013–1.481

0.007

1.273

1.068–1.517

Number of cycles

< 0.001

0.879

0.855–0.904

< 0.001

0.922

0.899–0.945

Treatment response

0.001

1.457

1.173–1.808

< 0.001

2.235

1.818–2.747

HBdec ≥ 30 g/L

0.001

1.536

1.206–1.957

< 0.001

1.543

1.233–1.932

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us